Article Details
Retrieved on: 2022-08-25 10:43:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zorifertinib is a next generation EGFR-TKI with full Blood Brain Barrier penetration targeting EGFRm+ NSCLC patients with CNS metastases Top-line ...
Article found on: www.einnews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here